MULTIZYME Trademark
Trademark Overview
On Friday, August 8, 1997, a trademark application was filed for MULTIZYME with the United States Patent and Trademark Office. The USPTO has given the MULTIZYME trademark a serial number of 75337661. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 26, 1998. This trademark is owned by Tyler Distribution Inc.. The MULTIZYME trademark is filed in the Pharmaceutical Products category with the following description:
dietary supplements
General Information
| Serial Number | 75337661 |
| Word Mark | MULTIZYME |
| Filing Date | Friday, August 8, 1997 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, October 26, 1998 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | dietary supplements |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Tyler Distribution Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Gresham, OR 97030 |
Trademark Events
| Event Date | Event Description |
| Monday, October 26, 1998 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, March 24, 1998 | NON-FINAL ACTION MAILED |
| Tuesday, March 17, 1998 | ASSIGNED TO EXAMINER |
